Chester County News and Community Website
WEST CONSHOHOCKEN, PA — The U.S. Food and Drug Administration has listed a patent covering HemiClor, a 12.5-milligram chlorthalidone tablet for treating hypertension, in its Orange Book, extending intellectual property …
FDA Lists HemiClor Patent, Extending Market Protection to 2045 Read More
WEST CONSHOHOCKEN, PA — PRM Pharma, LLC announced the nationwide launch of HemiClor® (chlorthalidone) 12.5 mg tablets, the first and only FDA-approved 12.5 mg formulation of chlorthalidone for adult hypertension. …
PRM Pharma Launches First FDA-Approved 12.5 mg Chlorthalidone for Hypertension Read More
WEST CONSHOHOCKEN, PA — PRM Pharma, LLC has announced the availability of HEMICLOR® (12.5 mg chlorthalidone tablets), the first FDA-approved low-dose formulation of chlorthalidone for the treatment of hypertension in …
PRM Pharma Launches HEMICLOR, First FDA-Approved Low-Dose Chlorthalidone Tablet Read More WEST CONSHOHOCKEN, PA — The U.S. Food and Drug Administration (FDA) has approved HemiClor, a 12.5 mg chlorthalidone tablet developed by PRM Pharma, LLC, for the treatment of hypertension in …
FDA Approves Low-Dose Hypertension Treatment HemiClor Read More